Abstract
The aim of the study was to evaluate the soluble form of intercellular adhesion molecule 1 (sICAM-1), a ligand of LFA-1, in the serum of patients with spondylarthropathies (SpA) and to look for a correlation with several inflammatory parameters. sICAM-1 levels were measured by ELISA in 25 SpA patients, 20 healthy controls and 20 patients with rheumatoid arthritis (RA). Results showed that sICAM-1 levels were increased (but not significantly) in SpA patients compared with controls; high levels (>400 ng/ml) where found in 28% of SpA patients but in none of the RA or control groups. In SpA, correlations were found between sICAM-1 and erythrocyte sedimentation rate, C-reactive protein and interleukin 6, but not with tumour necrosis factor alapha or IgA. These correlations were absent in RA. In conclusion, these results suggest that sICAM-1 levels in SpA may reflect the acute phase of inflammation.
Similar content being viewed by others
References
Cronstein BN, Weissmann G. The adhesion molecules of inflammation. Arthritis Rheum 1993;36:147–57.
Pitzalis C, Kingsley G, Panayi G. Adhesion molecules in rheumatoid arthritis: role in the pathogenesis and prospects for therapy. Ann Rheum Dis 1994;53:287–8.
Wendling D. Molécules d'adhésion au cours des rhumatismes inflammatoires. Presse Méd 1993;22:1945–7.
Cush JJ, Rothlein R, Lindsley HB, Mainolfi E, Lipsky PE. Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritis. Arthritis Rheum 1993;36:1098–102.
Aoki S, Imai K, Yachi A. Soluble intercellular adhesion molecule 1 (ICAM-1) antigen in patients with rheumatoid arthritis. Scand J Immunol 1993;38:485–90.
Voskuyla E, Martin S, Melchers I, Zwinderman AH, Weichselbraun I, Breedveld FC. Levels of circulating intercellular adhesion molecule 1 and 3 but not circulating endothelial leucocyte adhesion molecule are increased in patients with rheumatoid vasculitis. Br J Rheumatol 1995;34:311–5.
Mason JC, Kapahi P, Haskard DO. Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Arthritis Rheum 1993;36:519–27.
Kuryliszyn-Moskal A, Bernacka K, Klimiuk PA. Circulating intercellular adhesion molecule 1 in rheumatoid arthritis. Relationship to systemic vasculitis and microvascular injury in nailfold capillary microscopy. Clin Rheum 1996;15:367–73.
Wendling D, Racadot E, Viel JF. Expression of the adhesion molecule LFA-1 on peripheral blood leukocytes in spondylarthropathy. Rev Rhum 1994;61:21–5.
Amor B, Toubert A. Reactive arthropathy, Reiter's syndrome and enteric arthropathy in adults. In: Maddison PJ, Isenberg DA, Woo P, Gloss DN, editors. Oxford textbook of rheumatology, vol 2. Oxford: Oxford University Press, 1993:699–709.
Dougados M, Van Derlinden S, Juhlin R, et al. The European Spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34:1218–27.
Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991;147:3788–93.
Kahan A, Menkes CJ, Amor B. Soluble intercellular adhesion molecule-1 (sICAM-1) in systemic sclerosis. Rev Esp Reumatol 1993;20(suppl 1):130.
Tutuncu ZN, Bilgie A, Kennedy LG, Calin A. Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis. Ann Rheum Dis 1994;53:425–6.
Gratacos J, Collado A, Filella X, Sanmarti R, Canete J, Llena J et al. Serum cytokines (IL-6, TNFα, IL-1β and IFN-γ) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 1994;33:927–31.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wendling, D., Racadot, E., Augé, B. et al. Soluble intercellular adhesion molecule 1 in spondylarthropathies. Clin Rheumatol 17, 202–204 (1998). https://doi.org/10.1007/BF01451047
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01451047